Epidermal HLA-DR and the enhancement of cutaneous reactivity to superantigenic toxins in psoriasis - Wikidata - wikimedia - TriplyDB

Epidermal HLA-DR and the enhancement of cutaneous reactivity to superantigenic toxins in psoriasis

Epidermal HLA-DR and the enhancement of cutaneous reactivity to superantigenic toxins in psoriasis

http://www.wikidata.org/entity/Q33901930

about

Skin innate immune system in psoriasis: friend or foe?Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities.Role of staphylococcal superantigen in atopic dermatitis: influence on keratinocytes.Verruciform xanthoma: A view on the concepts of its etiopathogenesis.Streptococcal toxins: role in pathogenesis and disease.Activity of Antimicrobial Peptides and Conventional Antibiotics against Superantigen Positive Staphylococcus aureus Isolated from the Patients with Neoplastic and Inflammatory Erythrodermia.Cellular basis of verruciform xanthoma: immunohistochemical and ultrastructural characterization.Molecular pathophysiology of psoriasis and molecular targets of antipsoriatic therapy.

P2860

Q33764350-916C3E14-2763-473A-B2BE-8E3AB5AC7345 Q34327203-16B3036B-C02D-4D3D-893B-926609E7C379 Q37323970-CDA00CA7-3D9E-4783-99B5-AFE28187C8DE Q38191558-E85778BF-1525-495D-BE44-CC017382F470 Q38598360-AE450EC5-C75C-4ECB-B850-46B32F3655B1 Q40631705-8E07EDFF-7E8C-4992-B826-7A21320E35A4 Q42525126-D6407F1C-55CF-42DF-9BD4-4B2C098F0011 Q50590488-67F86C35-DDB8-40B1-AC24-942645F52C0B

P2860

Epidermal HLA-DR and the enhancement of cutaneous reactivity to superantigenic toxins in psoriasis

http://www.wikidata.org/entity/Q33901930

description

1999 nî lūn-bûn

@nan

1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

Epidermal HLA-DR and the enhan ...... rantigenic toxins in psoriasis

@ast

Epidermal HLA-DR and the enhan ...... rantigenic toxins in psoriasis

@en

type

label

Epidermal HLA-DR and the enhan ...... rantigenic toxins in psoriasis

@ast

Epidermal HLA-DR and the enhan ...... rantigenic toxins in psoriasis

@en

prefLabel

Epidermal HLA-DR and the enhan ...... rantigenic toxins in psoriasis

@ast

Epidermal HLA-DR and the enhan ...... rantigenic toxins in psoriasis

@en

P1433

Q33901930-18BDDBB4-CB51-4CE3-B2D3-8AD841D18E1D

P1476

Q33901930-0CB711DD-E01E-4273-A9CA-54981BCCA9E7

P2093

Q33901930-1F4C508F-E10E-40DC-B446-1D5DEFE4B2C3

Q33901930-29F6E1D7-9577-4453-AD43-C8CFEE7B0AAE

Q33901930-3B544749-AF0E-41B8-97DB-3FBBC11D68A3

Q33901930-5EC05F26-E6A3-4BD8-BB34-155E134FD9DC

Q33901930-A7DD59A1-9967-4B19-965C-B56CD5E4B7B7

Q33901930-B02A9209-38F9-4AD8-9058-ACD764A0D3DF

P2860

Q33901930-13A16888-BB2D-4E0F-BB82-9D6F134F1200

Q33901930-19D9C19F-4A8B-4DF4-803F-7F6520F33F63

Q33901930-1C4A82AC-D85B-4717-A750-E498B8B55F80

Q33901930-2D3382B5-9118-4A07-81C7-DC93ECD18819

Q33901930-2E989034-E91E-41B8-AED8-A57AA10F8323

Q33901930-3A0A1A97-A18D-4B2B-86AF-37C25D57F1D3

Q33901930-525A7436-C30F-4408-B81D-3F04CB0D0A0A

Q33901930-67168A23-D2B9-4AAC-AE4D-5A1B3840E0B9

Q33901930-732E43A0-7EE9-467B-940D-026F8F9EB6BA

Q33901930-7724B2C8-2C71-465E-A70A-E4B82947FB32

P304

Q33901930-4C1A9FC9-F181-4866-8811-859181AFD4B8

P31

Q33901930-274F8BAF-2DD5-4EB2-8158-F6914D429899

P356

Q33901930-614E820D-5CD9-4DC4-ADD6-99827A698197

P407

Q33901930-7EFDB65A-E5CA-4A1B-8C5D-0D868A5C368F

P433

Q33901930-1F3384BC-6BE2-406F-93CC-E95E22DA822C

P478

Q33901930-92F6F215-27B0-40CE-9B56-E272D172300D

P50

Q33901930-7717CE89-32FF-43F8-A89D-78A7F2AD464B

Q33901930-C7556DC5-CBDB-4909-95B2-BEBA1BAA04D4

P577

Q33901930-8711BC67-FE5D-49E9-9106-D78CBBB34BDE

P5875

Q33901930-273307A3-4D1D-47E8-BB89-1ABA70B1BCD6

P698

Q33901930-31D529F6-88D8-48E7-B4FB-0581C7F22600

P932

Q33901930-88F18144-E7EB-415B-ADAF-507898240954

P356

P1433

Journal of Clinical Investigation

P1476

Epidermal HLA-DR and the enhan ...... rantigenic toxins in psoriasis

@en

P2093

C Kuhn

http://www.w3.org/2001/XMLSchema#string

D A Norris

http://www.w3.org/2001/XMLSchema#string

D Y Leung

http://www.w3.org/2001/XMLSchema#string

E R Farmer

http://www.w3.org/2001/XMLSchema#string

Q A Hamid

http://www.w3.org/2001/XMLSchema#string

R C Giorno

http://www.w3.org/2001/XMLSchema#string

P2860

Examination of the epidermis by the strip method. II. Biometric data on regeneration of the human epidermis.

Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis. Evidence for a new group of allergens.

Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis.

Interaction of Staphylococcus aureus toxin "superantigens" with human T cells

Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis.

Localization of biologically important regions on toxic shock syndrome toxin 1.

Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice.

PUVA bath therapy strongly suppresses immunological and epidermal activation in psoriasis: a possible cellular basis for remittive therapy

Identification of class II major histocompatibility complex and T cell receptor binding sites in the superantigen toxic shock syndrome toxin 1

Staphylococcal enterotoxin B applied on intact normal and intact atopic skin induces dermatitis.

P304

1181-1189

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI6835

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

104

http://www.w3.org/2001/XMLSchema#string

P50

Patrick M. Schlievert

Jeffrey B Travers

P577

1999-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12754350

http://www.w3.org/2001/XMLSchema#string

P698

10545517

http://www.w3.org/2001/XMLSchema#string

P932

409817

http://www.w3.org/2001/XMLSchema#string